Breaking News Instant updates and real-time market news.

EARS

Auris Medical

$0.79 /

+0.0255 (+3.36%)

17:01
04/03/20
04/03
17:01
04/03/20
17:01

Auris Medical says Phase 2 trial with AM-125 to be affected by COVID-19

Auris Medical Holding provided an update on the impact of the COVID-19 pandemic on its ongoing clinical trials with intranasal betahistine. The Phase 1b trial with AM-201, intranasal betahistine for the prevention of antipsychotic-induced weight gain and somnolence, has remained unaffected by the COVID-19 pandemic. The last subject had its last treatment visit in early March 2020. The trial is now progressing towards the read-out of top-line data, which is expected for early May 2020, in accordance with previous guidance. The Phase 2 trial with AM-125, intranasal betahistine for the treatment of acute peripheral vertigo, will be impacted by the COVID-19 outbreak. The outbreak has delayed enrollment into the study. Candidates for participation in this trial undergo certain types of neurosurgery, which are classified as elective procedures. Due to the COVID-19 outbreak, the sites participating in the "TRAVERS" trial have postponed elective procedures and temporarily reduced or suspended clinical research activities. As a result, enrollment came to a halt towards the end of March 2020. Although sites are expected to catch up on enrollment once COVID-19 related restrictions are relaxed, the Company expects that the interim analysis following Part A of the trial will now be completed in the third quarter of 2020, at the earliest.

TODAY'S FREE FLY STORIES

Earnings
Akari Therapeutics reports Q1 EPS (0c) vs. (0c) last year » 07:13
05/29/20
05/29
07:13
05/29/20
07:13
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

"We remain focused…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Hot Stocks
Canopy Growth reports Q4 adjusted gross margin 42% » 07:13
05/29/20
05/29
07:13
05/29/20
07:13
CGC

Canopy Growth

$22.13 /

+2.26 (+11.37%)

Reported gross margin,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

05/22/20 BofA
Canopy Growth resumed with a Buy at BofA
05/14/20 Cantor Fitzgerald
Canopy Growth price target lowered to C$25 from C$27 at Cantor Fitzgerald
04/16/20
Fly Intel: Top five analyst upgrades
04/16/20 Jefferies
Canopy Growth upgraded to Hold following pullback at Jefferies
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

Hot Stocks
Kite Realty Group launches Re-opening Resources program » 07:12
05/29/20
05/29
07:12
05/29/20
07:12
KRG

Kite Realty Group

$10.32 /

-0.42 (-3.91%)

Kite Realty Group Trust…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRG Kite Realty Group
$10.32 /

-0.42 (-3.91%)

04/16/20 Compass Point
Kite Realty may need to reduce dividend, says Compass Point in downgrade
04/16/20 Compass Point
Kite Realty Group downgraded to Neutral from Buy at Compass Point
03/03/20
Kite raised to Buy, Retail Properties cut to sell in Compass Point REIT shake-up
03/03/20 Compass Point
Kite Realty Group upgraded to Buy from Neutral at Compass Point
KRG Kite Realty Group
$10.32 /

-0.42 (-3.91%)

Downgrade
Hugo Boss downgraded to Hold from Buy at Jefferies » 07:12
05/29/20
05/29
07:12
05/29/20
07:12
BOSSY

Hugo Boss

$0.00 /

+ (+0.00%)

Jefferies analyst Kathryn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BOSSY Hugo Boss
$0.00 /

+ (+0.00%)

05:29 Today DZ Bank
Hugo Boss downgraded to Hold from Buy at DZ Bank
05/07/20 HSBC
Hugo Boss price target lowered to EUR 26.50 from EUR 50 at HSBC
05/06/20 Deutsche Bank
Hugo Boss price target lowered to EUR 31 from EUR 35 at Deutsche Bank
05/06/20 JPMorgan
Hugo Boss price target lowered to EUR 41 from EUR 45 at JPMorgan
Hot Stocks
Aveo presents results from final analysis of Phase 3 TIVO-3 trial » 07:11
05/29/20
05/29
07:11
05/29/20
07:11
AVEO

Aveo Pharmaceuticals

$9.22 /

+0.47 (+5.37%)

Aveo announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

05/01/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $10 from $6 at H.C. Wainwright
04/01/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $6 from $4 at H.C. Wainwright
03/31/20 Piper Sandler
Aveo Pharmaceuticals price target lowered to $18.50 from $20 at Piper Sandler
03/18/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $4 from $1.75 at H.C. Wainwright
AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

Hot Stocks
Oncolytics: ePoster published from phase 1b study of pelareorep-carfilzomib » 07:10
05/29/20
05/29
07:10
05/29/20
07:10
ONCY

Oncolytics

$2.45 /

+0.14 (+6.06%)

Oncolytics announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONCY Oncolytics
$2.45 /

+0.14 (+6.06%)

ONCY Oncolytics
$2.45 /

+0.14 (+6.06%)

05/11/20 RBC Capital
Oncolytics price target lowered to C$6 from C$9 at RBC Capital
01/02/20 Roth Capital
Oncolytics price target raised to $9 from $6.80 at Roth Capital
09/04/19
Fly Intel: Top five analyst initiations
09/04/19 Roth Capital
Oncolytics initiated with a Buy at Roth Capital
Hot Stocks
Myriad Genetics presents new data on riskScore test » 07:10
05/29/20
05/29
07:10
05/29/20
07:10
MYGN

Myriad Genetics

$14.43 /

-0.15 (-1.03%)

Myriad Genetics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MYGN Myriad Genetics
$14.43 /

-0.15 (-1.03%)

MYGN Myriad Genetics
$14.43 /

-0.15 (-1.03%)

05/06/20 JPMorgan
Myriad Genetics price target lowered to $12 from $14 at JPMorgan
05/06/20 Piper Sandler
Myriad Genetics price target lowered to $14 from $20 at Piper Sandler
03/06/20 JPMorgan
Myriad Genetics price target lowered to $14 from $17 at JPMorgan
02/07/20 JPMorgan
Myriad Genetics price target lowered to $17 from $20 at JPMorgan
MYGN Myriad Genetics
$14.43 /

-0.15 (-1.03%)

MYGN Myriad Genetics
$14.43 /

-0.15 (-1.03%)

MYGN Myriad Genetics
$14.43 /

-0.15 (-1.03%)

Recommendations
Toll Brothers price target raised to $37 from $31 at RBC Capital » 07:09
05/29/20
05/29
07:09
05/29/20
07:09
TOL

Toll Brothers

$32.30 /

-0.65 (-1.97%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

05/27/20 Credit Suisse
Toll Brothers initiated with a Neutral at Credit Suisse
05/27/20 Credit Suisse
KB Home initiated with an Outperform at Credit Suisse
05/11/20 Wedbush
Toll Brothers price target lowered to $35 from $48 at Wedbush
05/04/20 Evercore ISI
Toll Brothers upgraded to In Line from Underperform at Evercore ISI
TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

Upgrade
Provident Financial upgraded to Buy from Hold at Jefferies » 07:09
05/29/20
05/29
07:09
05/29/20
07:09
FPLPY

Provident Financial

$0.00 /

+ (+0.00%)

Jefferies analyst Julian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FPLPY Provident Financial
$0.00 /

+ (+0.00%)

04/20/20 JPMorgan
Provident Financial price target lowered to 200 GBp from 240 GBp at JPMorgan
Hot Stocks
OraSure to acquire UrSure for cash » 07:08
05/29/20
05/29
07:08
05/29/20
07:08
OSUR

OraSure

$13.52 /

-0.1 (-0.73%)

OraSure Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OSUR OraSure
$13.52 /

-0.1 (-0.73%)

OSUR OraSure
$13.52 /

-0.1 (-0.73%)

04/21/20 Stephens
OraSure resumed with an Equal Weight at Stephens
OSUR OraSure
$13.52 /

-0.1 (-0.73%)

Hot Stocks
Apogee Enterprises appoints Nisheet Gupta as CFO » 07:08
05/29/20
05/29
07:08
05/29/20
07:08
APOG

Apogee Enterprises

$21.54 /

-0.53 (-2.40%)

Apogee Enterprises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APOG Apogee Enterprises
$21.54 /

-0.53 (-2.40%)

APOG Apogee Enterprises
$21.54 /

-0.53 (-2.40%)

04/03/20 DA Davidson
Apogee Enterprises price target lowered to $22 from $35 at DA Davidson
12/20/19 DA Davidson
Apogee Enterprises price target lowered to $35 from $40 at DA Davidson
06/28/19 Craig-Hallum
Apogee Enterprises price target raised to $52 after Q1 report at Craig-Hallum
APOG Apogee Enterprises
$21.54 /

-0.53 (-2.40%)

Recommendations
Lululemon price target raised to $335 from $250 at Raymond James » 07:08
05/29/20
05/29
07:08
05/29/20
07:08
LULU

Lululemon

$284.60 /

+2.91 (+1.03%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LULU Lululemon
$284.60 /

+2.91 (+1.03%)

LULU Lululemon
$284.60 /

+2.91 (+1.03%)

05/21/20
Lululemon reopened over 150 locations, to open another 200 in next 2 weeks
05/19/20 B. Riley FBR
Lululemon price target raised to $290 from $256 at B. Riley FBR
05/18/20 Piper Sandler
Lululemon price target raised to $265 from $249 at Piper Sandler
05/14/20 Cowen
Lululemon price target raised to $280 from $235 at Cowen
LULU Lululemon
$284.60 /

+2.91 (+1.03%)

LULU Lululemon
$284.60 /

+2.91 (+1.03%)

LULU Lululemon
$284.60 /

+2.91 (+1.03%)

LULU Lululemon
$284.60 /

+2.91 (+1.03%)

Hot Stocks
Canopy Growth withdraws previous milestones for positive adj. EBITDA, net income » 07:07
05/29/20
05/29
07:07
05/29/20
07:07
CGC

Canopy Growth

$22.13 /

+2.26 (+11.37%)

Canopy Growth expects…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

05/22/20 BofA
Canopy Growth resumed with a Buy at BofA
05/14/20 Cantor Fitzgerald
Canopy Growth price target lowered to C$25 from C$27 at Cantor Fitzgerald
04/16/20
Fly Intel: Top five analyst upgrades
04/16/20 Jefferies
Canopy Growth upgraded to Hold following pullback at Jefferies
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

Earnings
Circor reports Q1 adj. EPS 20c, consensus 45c » 07:07
05/29/20
05/29
07:07
05/29/20
07:07
CIR

Circor

$15.99 /

+0.385 (+2.47%)

Reports Q1 revenue $192M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CIR Circor
$15.99 /

+0.385 (+2.47%)

CIR Circor
$15.99 /

+0.385 (+2.47%)

12/30/19 Stifel
Stifel sees Crane's acquisition of Circor business accretive in 2020
09/17/19
Fly Intel: Top five analyst upgrades
09/17/19
Circor upgraded to Overweight at KeyBanc
09/17/19 KeyBanc
Circor upgraded to Overweight from Sector Weight at KeyBanc
CIR Circor
$15.99 /

+0.385 (+2.47%)

Recommendations
Ciena price target raised to $61 from $51 at Raymond James » 07:06
05/29/20
05/29
07:06
05/29/20
07:06
CIEN

Ciena

$54.80 /

-0.78 (-1.40%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CIEN Ciena
$54.80 /

-0.78 (-1.40%)

CIEN Ciena
$54.80 /

-0.78 (-1.40%)

05/27/20 Rosenblatt
Ciena price target raised to $59 from $51 at Rosenblatt
05/26/20 Jefferies
Ciena has 'at least a one-year lead' with Waveserver 5, says Jefferies
05/22/20 MKM Partners
Ciena price target raised to $62 from $54 at MKM Partners
05/13/20 B. Riley FBR
Ciena downgraded to Neutral on marco uncertainty at B. Riley FBR
CIEN Ciena
$54.80 /

-0.78 (-1.40%)

CIEN Ciena
$54.80 /

-0.78 (-1.40%)

CIEN Ciena
$54.80 /

-0.78 (-1.40%)

CIEN Ciena
$54.80 /

-0.78 (-1.40%)

Hot Stocks
Ceridian completes acquisition of Excelity Global » 07:06
05/29/20
05/29
07:06
05/29/20
07:06
CDAY

Ceridian

$67.95 /

+0.51 (+0.76%)

Ceridian announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDAY Ceridian
$67.95 /

+0.51 (+0.76%)

CDAY Ceridian
$67.95 /

+0.51 (+0.76%)

05/22/20 Piper Sandler
Piper expands Software coverage, favors companies that drive automation
05/21/20 Piper Sandler
Ceridian initiated with a Neutral at Piper Sandler
05/14/20 Stephens
Cannae Holdings price target raised to $43 from $40 at Stephens
05/10/20 Jefferies
Ceridian price target raised to $65 from $60 at Jefferies
CDAY Ceridian
$67.95 /

+0.51 (+0.76%)

CDAY Ceridian
$67.95 /

+0.51 (+0.76%)

Upgrade
Stock Yards Bancorp upgraded to Outperform from Market Perform at Raymond James » 07:05
05/29/20
05/29
07:05
05/29/20
07:05
SYBT

Stock Yards Bancorp

$35.05 /

-0.23 (-0.65%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYBT Stock Yards Bancorp
$35.05 /

-0.23 (-0.65%)

05:17 Today Raymond James
Stock Yards Bancorp upgraded to Outperform from Market Perform at Raymond James
04/09/20 Stephens
Stephens upgrades Old National, First Busey and S.Y. Bancorp to Overweight
04/09/20 Stephens
S.Y. Bancorp upgraded to Overweight from Equal Weight at Stephens
SYBT Stock Yards Bancorp
$35.05 /

-0.23 (-0.65%)

Downgrade
Trainline downgraded to Neutral from Overweight at JPMorgan » 07:05
05/29/20
05/29
07:05
05/29/20
07:05
TNLIF

Trainline

$0.00 /

+ (+0.00%)

JPMorgan analyst Marcus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
VMware price target raised to $181 from $165 at RBC Capital » 07:05
05/29/20
05/29
07:05
05/29/20
07:05
VMW

VMware

$142.79 /

+3.18 (+2.28%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VMW VMware
$142.79 /

+3.18 (+2.28%)

VMW VMware
$142.79 /

+3.18 (+2.28%)

06:46 Today Mizuho
VMware price target raised to $152 from $140 at Mizuho
04:56 Today Jefferies
VMware price target raised to $160 from $135 at Jefferies
05/27/20 BMO Capital
VMware price target lowered to $152 from $163 at BMO Capital
05/26/20 Morgan Stanley
Morgan Stanley sees risk to both Q1 and FY21 for VMware
VMW VMware
$142.79 /

+3.18 (+2.28%)

VMW VMware
$142.79 /

+3.18 (+2.28%)

VMW VMware
$142.79 /

+3.18 (+2.28%)

VMW VMware
$142.79 /

+3.18 (+2.28%)

Hot Stocks
iRadimed appoints Roger Susi as president, CEO » 07:05
05/29/20
05/29
07:05
05/29/20
07:05
IRMD

iRadimed

$22.24 /

+0.85 (+3.97%)

IRADIMED CORPORATION…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRMD iRadimed
$22.24 /

+0.85 (+3.97%)

IRMD iRadimed
$22.24 /

+0.85 (+3.97%)

04/13/20 Roth Capital
iRadimed price target lowered to $30 from $32 at Roth Capital
IRMD iRadimed
$22.24 /

+0.85 (+3.97%)

Earnings
Canopy Growth reports Q4 EPS (C$3.72) vs. (C$1.10) a year ago » 07:05
05/29/20
05/29
07:05
05/29/20
07:05
CGC

Canopy Growth

$22.13 /

+2.26 (+11.37%)

Reports Q4 net revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

05/22/20 BofA
Canopy Growth resumed with a Buy at BofA
05/14/20 Cantor Fitzgerald
Canopy Growth price target lowered to C$25 from C$27 at Cantor Fitzgerald
04/16/20
Fly Intel: Top five analyst upgrades
04/16/20 Jefferies
Canopy Growth upgraded to Hold following pullback at Jefferies
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

General news
FX Update: The yen has strengthened » 07:05
05/29/20
05/29
07:05
05/29/20
07:05

FX Update: The yen has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Masco double downgraded to Market Perform at Raymond James » 07:04
05/29/20
05/29
07:04
05/29/20
07:04
MAS

Masco

$46.83 /

-0.26 (-0.55%)

Raymond James analyst Sam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAS Masco
$46.83 /

-0.26 (-0.55%)

MAS Masco
$46.83 /

-0.26 (-0.55%)

05:16 Today Raymond James
Masco downgraded to Market Perform from Strong Buy at Raymond James
05/27/20 Credit Suisse
Masco initiated with an Outperform at Credit Suisse
04/30/20 Nomura Instinet
Masco price target raised to $56 from $52 at Nomura Instinet
04/14/20 Goldman Sachs
Owens Corning downgraded to Buy from Conviction Buy at Goldman Sachs
MAS Masco
$46.83 /

-0.26 (-0.55%)

MAS Masco
$46.83 /

-0.26 (-0.55%)

MAS Masco
$46.83 /

-0.26 (-0.55%)

Hot Stocks
GTY Technology Holdings budgeting unit selected to implement BFM in New Mexico » 07:04
05/29/20
05/29
07:04
05/29/20
07:04
GTYH

GTY Technology Holdings

$3.86 /

+0.41 (+11.88%)

GTY Technology Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTYH GTY Technology Holdings
$3.86 /

+0.41 (+11.88%)

GTYH GTY Technology Holdings
$3.86 /

+0.41 (+11.88%)

08/26/19 Citi
GTY Technology Holdings initiated with a Neutral at Citi
08/23/19 Citi
GTY Technology Holdings initiated with a Neutral at Citi
07/10/19
GTY Technology Holdings initiated with a Buy at Needham
07/09/19 Needham
GTY Technology Holdings initiated with a Buy at Needham
GTYH GTY Technology Holdings
$3.86 /

+0.41 (+11.88%)

Hot Stocks
Arvinas reports updated dose escalation data from trial of ARV-110 » 07:04
05/29/20
05/29
07:04
05/29/20
07:04
ARVN

Arvinas

$44.78 /

+1.93 (+4.50%)

Arvinas announced updated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARVN Arvinas
$44.78 /

+1.93 (+4.50%)

ARVN Arvinas
$44.78 /

+1.93 (+4.50%)

05/15/20 Roth Capital
Roth Capital maintains positive outlook on Arvinas after ASCO abstract review
05/13/20 Piper Sandler
Arvinas pullback represents a buying opportunity, says Piper Sandler
05/13/20 Wedbush
Arvinas removed from Best Ideas List at Wedbush
05/12/20
Fly Intel: Top five analyst initiations
ARVN Arvinas
$44.78 /

+1.93 (+4.50%)

ARVN Arvinas
$44.78 /

+1.93 (+4.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.